CHC
ACHN

City Holding Co’s Achillion Pharmaceuticals ACHN Stock Holding History

City Holding Co’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-275
Closed -$1K – 602
2017
Q2 		$1K Hold
275
– – ﹤0.01% 558
2017
Q1 		$1K Hold
275
– – ﹤0.01% 556
2016
Q4 		$1K Buy
+275
New +$1.46K ﹤0.01% 540

Other funds holding ACHN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

City Holding Co's ACHN Position: Q3 2017 in Review

City Holding Co sold out of Achillion Pharmaceuticals (ACHN) in Q3 2017, closing a stake of 275 shares — an estimated $1K sold.

City Holding Co first reported a position in ACHN in Q4 2016 and held it in 3 quarters. The position peaked at $1K in Q2 2017. 125 funds tracked by Wall St. Rank hold ACHN as of Q3 2017.

  • City Holding Co reported no remaining Achillion Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • City Holding Co sold 275 Achillion Pharmaceuticals shares in Q3 2017, an estimated $1K.
  • City Holding Co first reported a position in Achillion Pharmaceuticals in Q4 2016 and held it in 3 quarters.
  • City Holding Co's Achillion Pharmaceuticals position peaked at $1K in Q2 2017.
  • 125 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q3 2017.

Based on City Holding Co's 13F filing for Q3 2017, filed 17 Oct 2017.